REG - BlackRock Group Medtronic, Inc. - Form 8.3 - Medtronic, Inc. <Origin Href="QuoteRef">MDT.N</Origin>

MedtronicAnnouncement

10/11/2014 09:33

RNS Number : 3910W
BlackRock Group
06 November 2014
Ap19
FORM8.3
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.3OFTHEIRISHTAKEOVERPANEL ACT,1997,TAKEOVERRULES,2013
DEALINGSBYPERSONSWITHINTERESTSINRELEVANTSECURITIESREPRESENTING1%ORMORE
1. KEYINFORMATION
Nameofpersondealing(Note1)
BlackRock, Inc.
Companydealtin
Medtronic, Inc.
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate(Note2)
USD 0.10 common shares
Dateofdealing
05 November 2014
2. INTERESTSANDSHORTPOSITIONS
(a) Interestsandshortpositions(followingdealing)intheclassofrelevantsecuritydealtin(Note3)

Long
Short

Number

(%)
Number

(%)
(1)Relevantsecurities
60,345,595 (6.13%)
43,969 (0.00%)
(2)Derivatives(otherthanoptions)
973 (0.00%)
11,200 (0.00%)
(3)Optionsandagreementstopurchase/sell
0 (0.00%)
69,300 (0.00%)
Total
60,346,568 (6.13%)
124,469 (0.01%)
(b) Interestsandshortpositionsinrelevantsecuritiesofthecompany,otherthantheclassdealtin(Note3)
Classofrelevantsecurity:
Long
Short

Number

(%)
Number

(%)
(1)Relevantsecurities


(2)Derivatives(otherthanoptions)


(3)Optionsandagreementstopurchase/sell


Total



Ap20
1. DEALINGS(Note4)
(a) Purchasesandsales
Purchase/sale
Numberofrelevantsecurities
Priceperunit(Note5)
Purchase
16,428
USD 68.7000
Purchase
63,131
USD 68.8586
Purchase
844
USD 68.8791
Sale
5,498
USD 68.7000
Sale
1,100
USD 68.8000
 
Please note: there was also a Transfer In of 23,196 Shares.
(b) Derivativestransactions(otherthanoptionstransactions)
Productname,
e.g.CFD
Natureoftransaction
(Note6)
Numberofrelevantsecurities
(Note7)
Priceperunit
(Note5)




 
(c) Optionstransactionsinrespectofexistingrelevantsecurities
(i) Writing,selling,purchasingorvarying
Productname,
e.g.calloption
Writing,selling,purchasing,varyingetc.
Numberofsecurities towhichtheoptionrelates(Note7)
Exercise price
Type,e.g.American,Europeanetc.
Expiry date
Optionmoney paid/receivedperunit(Note5)







(ii) Exercising
Productname,
e.g.calloption
Numberofsecurities
Exercisepriceper unit(Note5)



(d) Otherdealings(includingtransactionsinrespectofnewsecurities)(Note4)
Natureoftransaction
(Note8)
Details
Priceperunit
(if applicable) (Note 5)



 Ap21
2. OTHERINFORMATION
Agreements,arrangementsorunderstandingsrelatingtooptionsorderivatives
Fulldetailsofanyagreement,arrangementorunderstandingbetween thepersondisclosing andanyotherpersonrelatingtothevotingrightsofanyrelevantsecuritiesunderanyoption referredtoonthisformorrelatingtothevotingrightsorfutureacquisitionordisposalofany
relevant securitiestowhichanyderivative referredtoonthisformisreferenced.Ifnone,this 
shouldbestated.
 None
IsaSupplementalForm8attached?(Note9) YES
Dateofdisclosure
06 November 2014
Contactname
Gareth Slade
Telephonenumber
+44 20 7743 2536
IfaconnectedEFM,nameofofferee/offerorwithwhichconnected

IfaconnectedEFM,statenatureofconnection(Note10)



Ap23
SUPPLEMENTALFORM8
IRISHTAKEOVERPANEL
DISCLOSUREUNDERRULE8.1ANDRULE8.3OFTHEIRISHTAKEOVERPANELACT,1997,TAKEOVERRULES,2013
DETAILSOFOPENPOSITIONS
(ThisformshouldbeattachedtoForm8.1(a)&(b)(i),Form8.1(b)(ii)orForm8.3,asappropriate)
OPENPOSITIONS(Note1)
Productname,
e.g.calloption
Written,orpurchased
Numberofrelevant securitiestowhichtheoptionorderivativerelates
Exercise price(Note2)
Type,e.g.American,Europeanetc.
Expiry date
Call Option
Written
21,100
USD 65.50
American
07/11/2014
Call Option
Written
35,700
USD 66.50
American
14/11/2014
Call Option
Written
12,500
USD 66.00
American
14/11/2014
Notes
1. Wherethereareopenoptionpositionsoropenderivative positions(exceptforCFDs),fulldetailsshouldbegiven.Fulldetailsofanyexistingagreementstopurchaseortosellmust alsobegivenonthisform.
2. Forallpricesandothermonetaryamounts,thecurrencymust bestated.
Forfulldetailsofdisclosurerequirements,seeRule8oftheRules.Ifindoubt,consultthePanel.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
ISEUNUVRSSAARAA